Masoud Keikha
About
In The Last Decade
Masoud Keikha
71 papers receiving 882 citations
Peers
Comparison fields: 5 of 104
- Surgery 389
- Molecular Biology 279
- Immunology 215
- Infectious Diseases 139
- Food Science 102
Countries citing papers authored by Masoud Keikha
This map shows the geographic impact of Masoud Keikha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masoud Keikha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masoud Keikha more than expected).
Fields of papers citing papers by Masoud Keikha
This network shows the impact of papers produced by Masoud Keikha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masoud Keikha. The network helps show where Masoud Keikha may publish in the future.
Co-authorship network of co-authors of Masoud Keikha
This figure shows the co-authorship network connecting the top 25 collaborators of Masoud Keikha. A scholar is included among the top collaborators of Masoud Keikha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masoud Keikha. Masoud Keikha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 8 | |
| 4 | 12 | |
| 5 | 3 | |
| 6 | 18 | |
| 7 | 4 | |
| 8 | 13 | |
| 9 | 99 | |
| 10 | 1 | |
| 11 | 69 | |
| 12 | 4 | |
| 13 | 43 | |
| 14 | The Indinavir Derivate as a Novel Pharmacophore for Treatment of HTLV-1 Viral Infections | 1 |
| 15 | 54 | |
| 16 | 10 | |
| 17 | 28 | |
| 18 | Can Curcumin be Used as an Anti-HIV Therapeutic Option? | 1 |
| 19 | 2 | |
| 20 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.